
Healthcare Spending Growth Expected to Remain Slow Until 2024
Healthcare spending growth between 2014 and 2024 is projected to be substantially lower than the 3 decades prior to 2008, according to a new report from CMS. In addition, the average premium for a basic Medicare Part D prescription plan will remain stable in 2016.
Healthcare spending growth between 2014 and 2024 is projected to be substantially lower than in previous years, according to a new report from CMS. Total healthcare spending is expected to average 5.8% over 2014 to 2024, compared with the 9% average seen in the 3 decades prior to 2008.
In 2014, healthcare spending in the US is projected to be $3.1 trillion, or $9,695 per person. This 5.5% increase over the previous year is associated with millions more gaining coverage and expensive specialty drugs coming to market. Overall, though, annual growth in per-enrollee expenditures remained slow for private health insurance (5.4%), Medicare (2.7%), and Medicaid (-0.8%).
“Growth in overall health spending remains modest even as more Americans are covered, many for the first time. Per-capita spending and medical inflation are all at historically very modest levels,” CMS Acting Administrator Andy Slavitt
An article about the study has been
CMS also released a report on the eve of the
“Seniors and people with disabilities are continuing to benefit from stable prescription drug premiums and a competitive and transparent marketplace for Medicare drug plans,” Mr Slavitt said. “While this is good news, we must ensure that Medicare Part D remains affordable for Medicare beneficiaries so that they can have access to the prescription drugs that they need.”
Total Part D costs per capita grew almost 11% in 2014, but growth in spending per Medicare enrollee is historically low. The growth per capita is largely driven by high-cost specialty drugs. With the continued historically low growth in per-Medicare enrollee spending, the most recent
For the past 5 years the average monthly premium for a basic Medicare Part D plan has been between $30 and $32.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.